In the last year, two new diseases have emerged with significant and lasting impact on the lung: E-cigarette or Vaping Product Use-Associated Lung Injury (EVALI) and COVID-19 pneumonia. This session will address new information and challenges related to both diseases. Vaping has increased in popularity, especially among youth, and in late 2019, EVALI was first described. While the outbreak has subsided, recognition of the symptoms, association with marijuana use, and radiographic findings of EVALI remain important. Further, providing tobacco and marijuana cessation guidance remains critical. The COVID-19 pandemic, caused by SARS-Cov2 virus, has burdened healthcare workers and scientists across the globe. COVID-19, often associated with severe pneumonia and systemic illness, has resulted in significant morbidity and mortality in the US and we can continue to learn and discover its full impact. Additionally, COVID-19 has unmasked major health disparities in our healthcare system that we must address.
Cancer Screening & Hematology: Patient-Centered Clinical Care of African Americans Episode 4: Bridging the Gap: Conversations with Dr. Hall
This session will provide an overview of the differences in the prevention and screening for select cancers (colon, prostate, breast, and lung) in African Americans. Discussion will focus on differences in the interpretation of common laboratory results including TSH, CBC, and others based on population outcome data.
This session will use four case presentations as a guide to review cancer and chronic disease differences and prevalence by race/ethnicity. Specific differences in diseases seen in Asian Americans and African Americans will be highlighted. Tobacco use and trends in different populations will also be emphasized.
Join us for the first COVID-19 Pulse session of 2021! In the twenty-fourth episode of Pri-Med’s web series on COVID-19, faculty will walk through the Advisory Committee on Immunization Practices (ACIP) guidelines for COVID-19 vaccine prioritization as well as the newest data on these vaccines. This session will discuss the emerging SARS-CoV-2 variants and their potential implications. Faculty will conclude with a Q&A session to answer your most pressing COVID-19 questions. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 12/15/2020 and they are subject to change as new information is published.
Join us for the final COVID-19 Pulse session of 2020! In the twenty-third episode of Pri-Med’s web series on COVID-19, faculty revisit the discussion of monoclonal antibodies, with a more in-depth look at the recent data and recommendations on monoclonal antibody use in COVID-19. Our learners also continue to have many questions about the relationship between COVID-19 and thrombotic complications. This session will discuss those questions as well as prophylaxis and treatment for venous thromboembolism in patients with COVID-19. Faculty will conclude with a Q&A session to answer your most pressing COVID-19 questions, including those about recent vaccine updates. Please note that any data, indications, and guidelines presented in this activity are current as of the recording/release on 12/15/2020 and they are subject to change as new information is published.
Clinicians often find themselves navigating a gauntlet of choices when recommending over the counter (OTC) medications for an acute viral respiratory illness. Decisions about NSAIDs, acetaminophen and aspirin to manage pain, inflammation and fever may now be more complicated given the COVID-19 pandemic. This session will dispel common misunderstandings about pain and fever reducing medications, with a focused discussion on some of the recent misconceptions surrounding NSAID use in relation to COVID-19. Faculty will present appropriate applications of NSAIDs and acetaminophen, based on current literature and evidence-based data.
This session will approach three challenging areas of infectious disease that the primary care clinician faces on a regular basis: sexually transmitted infections, vaccination, and hepatitis. In the past few years, there has been a tremendous rise in the incidence of sexually transmitted infections. Faculty will update the audience on recent developments in the management of patients with sexually transmitted infections. Also continually updated, are the guidelines on adult vaccination. This session will provide updates on the adult vaccination schedule. Lastly, faculty will discuss the epidemiology of viral hepatitis.
My COVID Experience and Renal & GI Disease Differences: Patient-Centered Clinical Care for African Americans
Episode 6: Bridging the Gap: Conversations with Dr. Hall
In this session, Dr. Hall will discuss his recent experience as a patient with COVID-19, which led to his admission to the ICU. Following this discussion, Dr. Hall will provide an overview of the health disparities related to kidney and gastrointestinal diseases in African Americans. Next, he will review the significantly increased incidence of renal disease and discuss some of the causes, including a genetic link. Infectious hepatitis demographics and other gastrointestinal disease differences will also be reviewed. Please note that any data, indications, and guidelines presented in this activity are current as of the recording on 1/19/2021 and they are subject to change as new information is published.
After implementing current guideline-directed medical management, there is still urgency to address residual cardiovascular risk. Among the drivers of residual cardiovascular risk, inflammation has generated considerable interest, first based on preclinical and biomarker studies in humans. More recently, translation has inspired clinical trials in this domain. This presentation will consider inflammation as a process that links traditional and nontraditional risk factors to atherothrombotic events.
In the twenty-second episode of Pri-Med’s web series on COVID-19, faculty will examine the concept of “herd immunity” and how it relates to the evolving COVID-19 pandemic. They will not only explain the basics of herd immunity but take a deep dive into why herd immunity may or may not help to limit the spread of COVID-19. This session will also re-visit the COVID-19 vaccine pipeline, explaining where we stand with current vaccine trials and the outlook for vaccine development.
ver 500,000 Americans of all ages and increases the risk of mortality by 3-4 times that of the general public. Yet, primary care providers receive little training on the specific health risks that affect the homeless nor on how to evaluate and care for these individuals. Join Dr. Chuck Vega as he tackles this vital but oft overlooked topic from a primary care point of view.
Guest: Susan Feeney, DNP, FNP-BCMusic Credit: Richard Onorato
Frankly Speaking, Live! STIs in the US are a major public health risk with an estimated 20 million new cases per year, more than half occurring in 15-24-year-olds. The USPSTF found intensive counseling in young adults to reduce the likelihood of STIs. Join us as we discuss how to apply these recommendations to your practice.